Chronic Obstructive Pulmonary Disease: Part IV A Review of Surgical Managements of Chronic Obstructive Pulmonary Disease
Main Article Content
Abstract
Medical and non-pharmacological treatments continue to be the initial managements for chronic obstructive pulmonary disease (COPD). These managements have evolved over time, but given the high mortality and morbidity of COPD, much work still needs to be done. To date, none of the existing pharmacological therapies for COPD has been shown conclusively to modify the long-term decline in lung function. Several trials have been completed to evaluate options that can improve patient symptoms and quality of life. Optimal management for patients with COPD requires both pharmacologic and non-pharmacologic managements. To date, the only treatments that can modify the course of COPD and potentially cure the disease are surgical treatments. Some of the surgical managements we discussed in this review include Lung Volume Reduction Surgeries (LVRS), Bronchoscopic Volume Reduction Surgery (BVRS), bullectomy and lung transplants. The indications for these surgical managements have also been discussed in this article. Patients for surgical managements have to be appropriately selected to avoid some of the major adverse events that can occur because of some of the treatment modality.
Keywords:
Lung Volume Reduction Surgeries, Bronchoscopic Volume Reduction Surgery (BVRS), bullectomy and lung transplants
Article Details
How to Cite
JOYCE, Akwe; FAIR, Nadine; FONGEH, Tatah.
Chronic Obstructive Pulmonary Disease: Part IV A Review of Surgical Managements of Chronic Obstructive Pulmonary Disease.
Medical Research Archives, [S.l.], v. 8, n. 3, mar. 2020.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/2063>. Date accessed: 08 may 2024.
doi: https://doi.org/10.18103/mra.v8i3.2063.
Section
Research Articles
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
1. Meyers BF, Patterson GA. Chronic obstructive pulmonary disease. 10: Bullectomy, lung volume reduction surgery, and transplantation for patients with chronic obstructive pulmonary disease. Thorax. 2003;58(7):634-638.
2. AGUSTI A. Gold Reports 2020 - Global Initiative for Chronic Obstructive ... https://goldcopd.org › 2019/11 › GOLD-2020-REPORT-ver1.0wms.pdf. Published 2019/11.
3. Weill D. Lung transplantation: indications and contraindications. J Thorac Dis. 2018;10(7):4574-4587.
4. Clarenbach CF, Sievi NA, Brock M, Schneiter D, Weder W, Kohler M. Lung Volume Reduction Surgery and Improvement of Endothelial Function and Blood Pressure in Patients with Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial. Am J Respir Crit Care Med. 2015;192(3):307-314.
5. Lando Y, Boiselle PM, Shade D, et al. Effect of lung volume reduction surgery on diaphragm length in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159(3):796-805.
6. Bellemare F, Cordeau MP, Couture J, Lafontaine E, Leblanc P, Passerini L. Effects of emphysema and lung volume reduction surgery on transdiaphragmatic pressure and diaphragm length. Chest. 2002;121(6):1898-1910.
7. Scott JP, Gillespie DJ, Peters SG, et al. Reduced work of breathing after single lung transplantation for emphysema. J Heart Lung Transplant. 1995;14(1 Pt 1):39-43.
8. Brath H, Lahrmann H, Wanke T, et al. The effect of lung transplantation on the neural drive to the diaphragm in patients with severe COPD. Eur Respir J. 1997;10(2):424-429.
9. Martinez FJ, de Oca MM, Whyte RI, Stetz J, Gay SE, Celli BR. Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med. 1997;155(6):1984-1990.
10. Teschler H, Stamatis G. [NETT confirms clear survival advantages by lung volume reduction in predominantly apical emphysema with reduced ability to cope with stress]. Pneumologie. 2003;57(7):361-362.
11. Naunheim KS, Wood DE, Mohsenifar Z, et al. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg. 2006;82(2):431-443.
12. Krachman SL, Chatila W, Martin UJ, et al. Effects of lung volume reduction surgery on sleep quality and nocturnal gas exchange in patients with severe emphysema. Chest. 2005;128(5):3221-3228.
13. Kozora E, Emery CF, Ellison MC, Wamboldt FS, Diaz PT, Make B. Improved neurobehavioral functioning in emphysema patients following lung volume reduction surgery compared with medical therapy. Chest. 2005;128(4):2653-2663.
14. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348(21):2059-2073.
15. Fessler HE, Scharf SM, Ingenito EP, McKenna RJ, Jr., Sharafkhaneh A. Physiologic basis for improved pulmonary function after lung volume reduction. Proc Am Thorac Soc. 2008;5(4):416-420.
16. Ingenito EP, Loring SH, Moy ML, Mentzer SJ, Swanson SJ, Reilly JJ. Interpreting improvement in expiratory flows after lung volume reduction surgery in terms of flow limitation theory. Am J Respir Crit Care Med. 2001;163(5):1074-1080.
17. Keller CA, Ruppel G, Hibbett A, Osterloh J, Naunheim KS. Thoracoscopic lung volume reduction surgery reduces dyspnea and improves exercise capacity in patients with emphysema. Am J Respir Crit Care Med. 1997;156(1):60-67.
18. Sciurba FC. Early and long-term functional outcomes following lung volume reduction surgery. Clin Chest Med. 1997;18(2):259-276.
19. Gorman RB, McKenzie DK, Butler JE, Tolman JF, Gandevia SC. Diaphragm length and neural drive after lung volume reduction surgery. Am J Respir Crit Care Med. 2005;172(10):1259-1266.
20. Bloch KE, Li Y, Zhang J, et al. Effect of surgical lung volume reduction on breathing patterns in severe pulmonary emphysema. Am J Respir Crit Care Med. 1997;156(2 Pt 1):553-560.
21. Jorgensen K, Houltz E, Westfelt U, Ricksten SE. Left ventricular performance and dimensions in patients with severe emphysema. Anesth Analg. 2007;104(4):887-892.
22. Zuwallack R. The nonpharmacologic treatment of chronic obstructive pulmonary disease: advances in our understanding of pulmonary rehabilitation. Proc Am Thorac Soc. 2007;4(7):549-553.
23. Celli BR, Decramer M, Wedzicha JA, et al. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. Eur Respir Rev. 2015;24(136):159-172.
24. Singh D, Agusti A, Anzueto A, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5).
25. Palla A, Desideri M, Rossi G, et al. Elective surgery for giant bullous emphysema: a 5-year clinical and functional follow-up. Chest. 2005;128(4):2043-2050.
26. Neviere R, Catto M, Bautin N, et al. Longitudinal changes in hyperinflation parameters and exercise capacity after giant bullous emphysema surgery. J Thorac Cardiovasc Surg. 2006;132(5):1203-1207.
27. Greenberg JA, Singhal S, Kaiser LR. Giant bullous lung disease: evaluation, selection, techniques, and outcomes. Chest Surg Clin N Am. 2003;13(4):631-649.
28. Lederer DJ, Arcasoy SM. Update in surgical therapy for chronic obstructive pulmonary disease. Clin Chest Med. 2007;28(3):639-653, vii.
29. Trulock EP, Christie JD, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant. 2007;26(8):782-795.
30. Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points. J Heart Lung Transplant. 2001;20(9):935-941.
31. Patel N, DeCamp M, Criner GJ. Lung transplantation and lung volume reduction surgery versus transplantation in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):447-453.
32. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005-1012.
33. Connors AF, Jr., Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med. 1996;154(4 Pt 1):959-967.
34. Ramsey SD, Shroyer AL, Sullivan SD, Wood DE. Updated evaluation of the cost-effectiveness of lung volume reduction surgery. Chest. 2007;131(3):823-832.
35. Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med. 2001;164(3):358-364.
36. Levine SM, Anzueto A, Peters JI, et al. Medium term functional results of single-lung transplantation for endstage obstructive lung disease. Am J Respir Crit Care Med. 1994;150(2):398-402.
37. Sundaresan RS, Shiraishi Y, Trulock EP, et al. Single or bilateral lung transplantation for emphysema? J Thorac Cardiovasc Surg. 1996;112(6):1485-1494; discussion 1494-1485.
38. T5C4VTGBavaria JE, Kotloff R, Palevsky H, et al. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg. 1997;113(3):520-527; discussion 528.
39. Cassivi SD, Meyers BF, Battafarano RJ, et al. Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg. 2002;74(5):1663-1669; discussion 1669-1670.
40. Wanke T, Merkle M, Formanek D, et al. Effect of lung transplantation on diaphragmatic function in patients with chronic obstructive pulmonary disease. Thorax. 1994;49(5):459-464.
41. Lanuza DM, Lefaiver C, Mc Cabe M, Farcas GA, Garrity E, Jr. Prospective study of functional status and quality of life before and after lung transplantation. Chest. 2000;118(1):115-122.
42. Dorffner R, Eibenberger K, Youssefzadeh S, et al. Diaphragmatic dysfunction after heart or lung transplantation. J Heart Lung Transplant. 1997;16(5):566-569.
43. McKenna RJ, Jr., Benditt JO, DeCamp M, et al. Safety and efficacy of median sternotomy versus video-assisted thoracic surgery for lung volume reduction surgery. J Thorac Cardiovasc Surg. 2004;127(5):1350-1360.
44. Pochettino A, Kotloff RM, Rosengard BR, et al. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease: intermediate-term results. Ann Thorac Surg. 2000;70(6):1813-1818; discussion 1818-1819.
45. Haverich A. Experience with lung transplantation. In: Ann Thorac Surg. Vol 67. Netherlands1999:305-312.
46. Weinstein MS, Martin UJ, Crookshank AD, et al. Mortality and functional performance in severe emphysema after lung volume reduction or transplant. Copd. 2007;4(1):15-22.
2. AGUSTI A. Gold Reports 2020 - Global Initiative for Chronic Obstructive ... https://goldcopd.org › 2019/11 › GOLD-2020-REPORT-ver1.0wms.pdf. Published 2019/11.
3. Weill D. Lung transplantation: indications and contraindications. J Thorac Dis. 2018;10(7):4574-4587.
4. Clarenbach CF, Sievi NA, Brock M, Schneiter D, Weder W, Kohler M. Lung Volume Reduction Surgery and Improvement of Endothelial Function and Blood Pressure in Patients with Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial. Am J Respir Crit Care Med. 2015;192(3):307-314.
5. Lando Y, Boiselle PM, Shade D, et al. Effect of lung volume reduction surgery on diaphragm length in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159(3):796-805.
6. Bellemare F, Cordeau MP, Couture J, Lafontaine E, Leblanc P, Passerini L. Effects of emphysema and lung volume reduction surgery on transdiaphragmatic pressure and diaphragm length. Chest. 2002;121(6):1898-1910.
7. Scott JP, Gillespie DJ, Peters SG, et al. Reduced work of breathing after single lung transplantation for emphysema. J Heart Lung Transplant. 1995;14(1 Pt 1):39-43.
8. Brath H, Lahrmann H, Wanke T, et al. The effect of lung transplantation on the neural drive to the diaphragm in patients with severe COPD. Eur Respir J. 1997;10(2):424-429.
9. Martinez FJ, de Oca MM, Whyte RI, Stetz J, Gay SE, Celli BR. Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med. 1997;155(6):1984-1990.
10. Teschler H, Stamatis G. [NETT confirms clear survival advantages by lung volume reduction in predominantly apical emphysema with reduced ability to cope with stress]. Pneumologie. 2003;57(7):361-362.
11. Naunheim KS, Wood DE, Mohsenifar Z, et al. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg. 2006;82(2):431-443.
12. Krachman SL, Chatila W, Martin UJ, et al. Effects of lung volume reduction surgery on sleep quality and nocturnal gas exchange in patients with severe emphysema. Chest. 2005;128(5):3221-3228.
13. Kozora E, Emery CF, Ellison MC, Wamboldt FS, Diaz PT, Make B. Improved neurobehavioral functioning in emphysema patients following lung volume reduction surgery compared with medical therapy. Chest. 2005;128(4):2653-2663.
14. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348(21):2059-2073.
15. Fessler HE, Scharf SM, Ingenito EP, McKenna RJ, Jr., Sharafkhaneh A. Physiologic basis for improved pulmonary function after lung volume reduction. Proc Am Thorac Soc. 2008;5(4):416-420.
16. Ingenito EP, Loring SH, Moy ML, Mentzer SJ, Swanson SJ, Reilly JJ. Interpreting improvement in expiratory flows after lung volume reduction surgery in terms of flow limitation theory. Am J Respir Crit Care Med. 2001;163(5):1074-1080.
17. Keller CA, Ruppel G, Hibbett A, Osterloh J, Naunheim KS. Thoracoscopic lung volume reduction surgery reduces dyspnea and improves exercise capacity in patients with emphysema. Am J Respir Crit Care Med. 1997;156(1):60-67.
18. Sciurba FC. Early and long-term functional outcomes following lung volume reduction surgery. Clin Chest Med. 1997;18(2):259-276.
19. Gorman RB, McKenzie DK, Butler JE, Tolman JF, Gandevia SC. Diaphragm length and neural drive after lung volume reduction surgery. Am J Respir Crit Care Med. 2005;172(10):1259-1266.
20. Bloch KE, Li Y, Zhang J, et al. Effect of surgical lung volume reduction on breathing patterns in severe pulmonary emphysema. Am J Respir Crit Care Med. 1997;156(2 Pt 1):553-560.
21. Jorgensen K, Houltz E, Westfelt U, Ricksten SE. Left ventricular performance and dimensions in patients with severe emphysema. Anesth Analg. 2007;104(4):887-892.
22. Zuwallack R. The nonpharmacologic treatment of chronic obstructive pulmonary disease: advances in our understanding of pulmonary rehabilitation. Proc Am Thorac Soc. 2007;4(7):549-553.
23. Celli BR, Decramer M, Wedzicha JA, et al. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. Eur Respir Rev. 2015;24(136):159-172.
24. Singh D, Agusti A, Anzueto A, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5).
25. Palla A, Desideri M, Rossi G, et al. Elective surgery for giant bullous emphysema: a 5-year clinical and functional follow-up. Chest. 2005;128(4):2043-2050.
26. Neviere R, Catto M, Bautin N, et al. Longitudinal changes in hyperinflation parameters and exercise capacity after giant bullous emphysema surgery. J Thorac Cardiovasc Surg. 2006;132(5):1203-1207.
27. Greenberg JA, Singhal S, Kaiser LR. Giant bullous lung disease: evaluation, selection, techniques, and outcomes. Chest Surg Clin N Am. 2003;13(4):631-649.
28. Lederer DJ, Arcasoy SM. Update in surgical therapy for chronic obstructive pulmonary disease. Clin Chest Med. 2007;28(3):639-653, vii.
29. Trulock EP, Christie JD, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant. 2007;26(8):782-795.
30. Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points. J Heart Lung Transplant. 2001;20(9):935-941.
31. Patel N, DeCamp M, Criner GJ. Lung transplantation and lung volume reduction surgery versus transplantation in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):447-453.
32. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005-1012.
33. Connors AF, Jr., Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med. 1996;154(4 Pt 1):959-967.
34. Ramsey SD, Shroyer AL, Sullivan SD, Wood DE. Updated evaluation of the cost-effectiveness of lung volume reduction surgery. Chest. 2007;131(3):823-832.
35. Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med. 2001;164(3):358-364.
36. Levine SM, Anzueto A, Peters JI, et al. Medium term functional results of single-lung transplantation for endstage obstructive lung disease. Am J Respir Crit Care Med. 1994;150(2):398-402.
37. Sundaresan RS, Shiraishi Y, Trulock EP, et al. Single or bilateral lung transplantation for emphysema? J Thorac Cardiovasc Surg. 1996;112(6):1485-1494; discussion 1494-1485.
38. T5C4VTGBavaria JE, Kotloff R, Palevsky H, et al. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg. 1997;113(3):520-527; discussion 528.
39. Cassivi SD, Meyers BF, Battafarano RJ, et al. Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg. 2002;74(5):1663-1669; discussion 1669-1670.
40. Wanke T, Merkle M, Formanek D, et al. Effect of lung transplantation on diaphragmatic function in patients with chronic obstructive pulmonary disease. Thorax. 1994;49(5):459-464.
41. Lanuza DM, Lefaiver C, Mc Cabe M, Farcas GA, Garrity E, Jr. Prospective study of functional status and quality of life before and after lung transplantation. Chest. 2000;118(1):115-122.
42. Dorffner R, Eibenberger K, Youssefzadeh S, et al. Diaphragmatic dysfunction after heart or lung transplantation. J Heart Lung Transplant. 1997;16(5):566-569.
43. McKenna RJ, Jr., Benditt JO, DeCamp M, et al. Safety and efficacy of median sternotomy versus video-assisted thoracic surgery for lung volume reduction surgery. J Thorac Cardiovasc Surg. 2004;127(5):1350-1360.
44. Pochettino A, Kotloff RM, Rosengard BR, et al. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease: intermediate-term results. Ann Thorac Surg. 2000;70(6):1813-1818; discussion 1818-1819.
45. Haverich A. Experience with lung transplantation. In: Ann Thorac Surg. Vol 67. Netherlands1999:305-312.
46. Weinstein MS, Martin UJ, Crookshank AD, et al. Mortality and functional performance in severe emphysema after lung volume reduction or transplant. Copd. 2007;4(1):15-22.